Demidova, T. Y., Krasil’nikova, E. I., Vorob’ev, S. V., Morugova, T. V., & Adasheva, T. V. (2021). The use of drug based on technologically processed antibodies to endocannabinoid receptor type 1 in the treatment of obesity in adults: Results of a multicenter double blind placebo controlled randomized clinical trial. "Consilium Medicum" Publishing house.
Style de citation Chicago (17e éd.)Demidova, Tatiana Y., Elena I. Krasil’nikova, Sergey V. Vorob’ev, Tatiana V. Morugova, et Tatiana V. Adasheva. The Use of Drug Based on Technologically Processed Antibodies to Endocannabinoid Receptor Type 1 in the Treatment of Obesity in Adults: Results of a Multicenter Double Blind Placebo Controlled Randomized Clinical Trial. "Consilium Medicum" Publishing house, 2021.
Style de citation MLA (8e éd.)Demidova, Tatiana Y., et al. The Use of Drug Based on Technologically Processed Antibodies to Endocannabinoid Receptor Type 1 in the Treatment of Obesity in Adults: Results of a Multicenter Double Blind Placebo Controlled Randomized Clinical Trial. "Consilium Medicum" Publishing house, 2021.